Associate Director, Tax and Accounting

Vir Biotechnology•San Francisco, CA

10h•$162,500 - $227,500•Hybrid

About The Position

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes programs for chronic hepatitis delta and multiple PRO-XTEN® dual-masked T-cell engagers across validated targets in solid tumor indications. Vir Biotechnology also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Vir Biotechnology has exclusive rights to the universal PRO-XTEN® masking platform for oncology and infectious disease. PRO-XTEN® is a trademark of Amunix Pharmaceuticals, Inc., a Sanofi company. We believe the success of our colleagues drives the success of our mission. We are committed to creating a company where everyone feels supported and encouraged to give their best. Vir Bio is looking for an Associate Director, Tax and Accounting, where you'll serve in a highly visible, strategic role with significant impact on our global tax posture as we transition from an R&D organization into a commercial-stage company. You will be responsible for all aspects of the Company’s global tax function, including tax strategy, tax provision, compliance, planning, and risk management. Reporting to the Chief Accounting Officer, this role is currently an individual contributor position with the potential opportunity to build and lead a tax team as the company grows and commercializes its products. The ideal candidate has deep experience in corporate tax for multinational organizations, including commercialization of products, supply-chain / IP planning, and operating in a loss-making, pre-commercial environment that evolves into revenue-generating operations. This role is located in our San Francisco headquarters with an expectation of 3 days per week in office.

Requirements

Bachelor’s degree in Accounting, Finance, or related field is required.
CPA and/or advanced degree in Tax (e.g., MST, JD/LLM in Tax) strongly preferred.
10+ years of progressive corporate tax experience, including significant experience in multinational corporate environments (public company or large private).
Strong technical expertise in U.S. federal and state corporate income tax, ASC 740, and international tax.
Demonstrated experience as the lead owner of the tax provision and global tax compliance, either in-house or as a senior advisor.
Proven experience supporting or leading tax aspects of commercialization and product launch (preferably in biotech/pharma or a similarly regulated industry).
Hands-on, “roll up your sleeves” approach; comfortable operating as a sole tax resource while building scalable processes.
Experience in biotechnology, pharmaceutical, or life sciences industries preferred, ideally in a high-growth or pre-commercial to commercial transition environment
Familiarity with supply chain tax optimization, transfer pricing and IP planning in the context of product launches preferred

Responsibilities

Oversee the quarterly and annual income tax provision process (ASC 740), including calculations (prepared by external tax service providers), documentation, internal controls, and support for external auditors
Evaluate uncertain tax positions, valuation allowances, and the tax implications of equity compensation and other complex transactions
Ensure accurate and timely tax disclosures for SEC filings (10-Q, 10-K, and other public reporting as applicable)
Act as the company’s “Head of Tax,” providing strategic and tactical tax guidance to senior management and cross-functional stakeholders.
Oversee global income tax compliance, including U.S. federal, state, and local filings prepared by external tax service providers, as well as coordination of foreign tax filings.
Manage external tax advisors and service providers to ensure high-quality, cost-effective support.
Establish and maintain tax-related internal controls and documentation in alignment with SOX and company policies.
Monitor and assess the impact of evolving tax legislation (e.g., U.S. tax reform, OECD Pillar Two, global minimum tax) on the company and advise senior leadership accordingly.
Develop and execute a comprehensive global tax strategy aligned with the Company’s business objectives, capital structure, and U.S. commercialization plans.
Partner with Finance, Accounting, Legal, and Business Development to structure commercial arrangements, licensing, collaborations, and supply-chain models in a tax-efficient and compliant manner.
Lead tax planning for the anticipated commercial launch of our Hepatitis Delta product in the U.S., including manufacturing and distribution structures, as well a potentially transfer pricing and cross-border cash repatriation.
Evaluate and optimize the use of net operating losses (NOLs), tax credits, and other attributes, including in the U.S. and our foreign subsidiaries.
Serve as the primary tax partner to commercial, supply chain, and operations teams as we prepare for and execute product launch within the U.S.
Work with supply chain and assist with any sales and use tax requirements as we prepare for the U.S. launch of our HDV program (assistance from tax consultants)
Advise on tax aspects of product pricing, distribution agreements, inventory flows, and third-party manufacturing and logistics arrangements.
Support evaluation and implementation of transfer pricing policies and documentation.
Manage the Company’s corporate insurance (assistance from our insurance broker).
Handle any VAT tax questions (assistance from tax consultants including international tax consultant)
Assist supply chain with federal and state sales and use tax questions (assistance from tax consultants)
Lead for other tax related questions including payroll (assistance from tax payroll consultant), franchise/local taxes and property taxes.
Support government related inquiries including census bureau questionnaires
Support team with reviewing potential impacts of tariffs
Communicate complex tax concepts clearly and proactively to non-tax stakeholders, including the executive team and audit committee as needed.